Product

IXCHIQ®powder and solvent for solution for injection. Chikungunya vaccine (live).

IXCHIQ^® is a live vaccine licensed to help prevent chikungunya.¹ It is indicated in the UK for active immunisation for the prevention of disease caused by CHIKV in individuals aged 18 years to 59 years.¹

IXCHIQ® overview

Get a useful overview of IXCHIQ®, including key facts about the vaccine.

Clinical data

Explore the latest clinical data on the efficacy and safety profile of IXCHIQ®.

Dosing and administration

Learn about the IXCHIQ® dosing schedule and co-administration with other vaccines.

View Prescribing Information Further information on SMPC Further information on PIL

Place an order

References

IXCHIQ. Summary of Product Characteristics. February 2026. Available at: www.medicines.org.uk/emc/product/100652/smpc. (Accessed March 2026).

Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to the Valneva UK Ltd Medical Information department on Tel: 01506 446608 or via email: safety@valneva.com